Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-24T12:59:06.291Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticipatory Nausea and Vomiting Among Ovarian, Lymphoma, and Breast Cancer Patients Receiving Chemotherapy: Implications for Behavioural Treatment

Published online by Cambridge University Press:  06 October 2014

Peter W. Dunne ,
Matthew R. Sanders  and
John H. Kearsley
Peter W. Dunne
Affiliation:
Royal Brisbane Hospital andUniversity of Queensland
Matthew R. Sanders
Affiliation:
Royal Brisbane Hospital andUniversity of Queensland
John H. Kearsley
Affiliation:
Royal Brisbane Hospital andUniversity of Queensland
Get access

Abstract

Cancer patients undergoing chemotherapy frequently experience anticipatory distress before treatment sessions. Eighty-six cancer patients (ovarian, lymphoma and breast) were assessed to determine the prevalence of anticipatory nausea and vomiting (ANV). Approximately one patient in three reported anticipatory nausea (AN), and of these 6 also experienced anticipatory vomiting (AV). Several patients reported anticipatory anxiety without any sensation of nausea. Clinically the notion of anticipatory distress may be more fruitful so that the problem of pretreatment anxiety is also addressed. Generally, AN was rated as moderate or worse in severity, occurred fairly consistently, and often began well before arrival at hospital on treatment day. It is suggested that future research should endeavour to link more closely the topography of the problem and the intervention techniques employed, as well as evaluating a broader range of possible interventions.

Type
Research Article
Information
Behaviour Change , Volume 9 , Issue 1 , March 1992 , pp. 25 - 31
Copyright
Copyright © The Author(s) 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Anderson, B.L., & Hacker, N.F. (1983). Treatment for gynecologic cancer: A review of the effects on female sexuality. Health Psychology, 2, 203–221.CrossRefGoogle Scholar
Andrykowski, M.A. (1986). Definitional issues in the study of anticipatory nausea in cancer chemotherapy, Journal of Behavioural Medicine, 9, 33–41.CrossRefGoogle Scholar
Andrykowski, M.A., Jacobsen, P.B., Marks, E., Garfinkle, K., Mares, T.B., Kaufman, J., Currie, V.E., Holland, J.C., & Redd, W.H. (1988). Prevalence, predictors and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer, 62, 2607–2613.3.0.CO;2-S>CrossRefGoogle ScholarPubMed
Andrykowski, M.A., Redd, W.H., & Hatfieild, A.K. (1985). Development of anticipatory nausea: A prospective analysis. Journal of Consulting and Clinical Psychology, 53, 447–454.CrossRefGoogle ScholarPubMed
Burish, T.G., & Lyles, J.N. (1979). Effectiveness of relaxation training in reducing the aversiveness of chemotherapy in the treatment of cancer. Behavior Therapy and Experimental Psychiatry, 10, 357–361.CrossRefGoogle Scholar
Burish, T.G., & Lyles, J.N. (1981). Effectiveness of relaxation training in reducing adverse reactions to cancer chemotherapy. Journal of Behavioural Medicine, 4, 65–78.CrossRefGoogle ScholarPubMed
Burish, T.G., & Lyles, J.N. (1983). Coping with the adverse effects of cancer treatments. In Burish, T.G. & Bradley, L.A. (Eds), Coping with chronic disease: Research and applications (pp. 159–189). New York: Academic Press.Google Scholar
Cararike, C.L.M., & Carey, M.P. (1990). Assessing nausea and vomiting in adult chemotherapy patients: Review and recommendations. Annals of Behavioral Medicine, 12, 79–85.Google Scholar
Cohen, R.E., Blanchard, E.B., Ruckdeschel, J.C., & Smolen, R.C. (1986). Prevalence and correlates of post-treatment and anticipatory nausea and vomiting in cancer chemotherapy. Journal of Psychosomatic Research, 30, 643–654.CrossRefGoogle Scholar
Coons, H.L., Leventhal, H., Nerenz, D.R., Love, R.R., & Larson, S. (1987). Anticipatory nausea and emotional distress in patients receiving cisplatin-based chemotherapy. Oncology Nursing Forum, 14, 31–35.Google ScholarPubMed
Dolgin, M.J., Katz, E.R., Zeltzer, L.K., & Landsverk, J. (1989). Behavioral distress in pediatric patients with cancer receiving chemotherapy. Pediatrics, 84, 103–110.CrossRefGoogle ScholarPubMed
Fetting, J.H., Wilcox, P.M., Iwata, B.A., Criswell, E.L., Bosmajian, L.S., & Scheidler, V.R. (1983). Anticipatory nausea and vomiting in an ambulatory medical oncology population. Cancer Treatment Reports, 67, 1093–1098.Google Scholar
Greenberg, D.B., Surman, O.S., Clarke, J., & Baer, L. (1987). Alprazolam for phobic nausea and vomiting related to cancer chemotherapy. Cancer Treatment Reports, 71, 549–550.Google ScholarPubMed
Greene, P.G., & Seime, R.J. (1987). Stimulus control of anticipatory nausea in cancer chemotherapy. Journal of Behavior Therapy and Experimental Psychiatry, 7, 61–64.CrossRefGoogle Scholar
Ingle, R.J., Burish, T.G., & Wallston, K.A. (1984). Conditionability of cancer chemotherapy patients. Oncology Nursing Forum, 11, 97–102.Google ScholarPubMed
Kolko, D.J., & Rickard-Figueroa, J.L. (1985). Effects of video games on the adverse corollaries of chemotherapy in pediatric oncology patients: A single-case analysis. Journal of Consulting and Clinical Psychology, 53, 223–228.CrossRefGoogle ScholarPubMed
Laszlo, J. (1982). Anticipatory nausea and vomiting with chemotherapy. The New England Journal of Medicine, 306, 432.Google Scholar
Meyerowitz, B.E. (1980). Psychosocial correlates of breast cancer and its treatment. Psychological Bulletin, 87, 108–131.CrossRefGoogle Scholar
Morrow, G.R. (1984). The assessment of nausea and vomiting: Past problems, current issues and suggestions for future research. Cancer, 53, 2267–2278.CrossRefGoogle ScholarPubMed
Morrow, G.R. (1985). The effect of susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer, 55, 2766–2770.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Morrow, G.R. (1986). Effect of the cognitive hierarchy on the systematic desensitisation treatment of anticipatory nausea in cancer patients: A component comparison with relaxation only, counselling and no treatment. Cognitive Therapy and Research, 10, 421–446.CrossRefGoogle Scholar
Morrow, G.R., & Dobkin, P.L. (1988). Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: Prevalence, etiology and behavioural interventions. Clinical Psychology Review, 8, 517–556.CrossRefGoogle Scholar
Morrow, G.R., & Morrell, B.S. (1982). Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. The New England Journal of Medicine, 307, 1476–1480.CrossRefGoogle ScholarPubMed
Redd, W.H., Jacobsen, P.B., Die-Trill, M., Dermatis, H., McEvoy, M., & Holland, J.C. (1987). Cognitive/attentional distraction in the control of conditioned-nausea in pediatric cancer patients receiving chemotherapy. Journal of Consulting and Clinical Psychology, 55, 391–395.CrossRefGoogle ScholarPubMed
Van Komen, R.W., & Redd, W.H. (1985). Personality factors associated with anticipatory nausea/vomiting in patients receiving cancer chemotherapy. Health Psychology, 4, 189–202.CrossRefGoogle ScholarPubMed
Weddington, W.W. (1982). Psychogenic nausea and vomiting associated with cancer chemotherapy. Psychotherapy and Psychosomatics, 37, 129–136.CrossRefGoogle ScholarPubMed
Weddington, W.W., Miller, N.J., & Sweet, D.L. (1984). Anticipatory nausea and vomiting associated with cancer chemotherapy. Journal of Psychosomatic Research, 28, 73–77.CrossRefGoogle ScholarPubMed
Wilcox, P.M., Fetting, J.H., Nettesheim, K.M., & Abeloff, M.D. (1982). Anticipatory vomiting in women receiving cyclophosphamide, methotrexate and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treatment Reports, 66, 1601–1604.Google ScholarPubMed